格拉菲特Rx和Mark Cuban的Cost Plus药物公司扩大合作伙伴关系, GraphiteRx and Mark Cuban’s Cost Plus Drugs expand partnership to cut medication costs by over 50% for healthcare providers.

格拉菲特Rx和马克古巴成本加药公司扩大了他们的合作伙伴关系, 加强成本加药市场, 使医院,药房和诊所可以在许多药品上节省50%以上. GraphiteRx and Mark Cuban Cost Plus Drugs have expanded their partnership to enhance the Cost Plus Marketplace for Businesses, enabling hospitals, pharmacies, and clinics to save over 50% on many medications. 合作将成本加药物的透明定价与GreatiteRx的数字平台结合起来,提供实时成本可见度、储蓄跟踪以及与临床系统的整合。 The collaboration combines Cost Plus Drugs’ transparent pricing with GraphiteRx’s digital platform, offering real-time cost visibility, savings tracking, and integration with clinical systems. 这项努力旨在改善在持续的保健财政压力下获得负担得起的可靠药物的机会,支持为全国数百万病人服务的提供者。 The effort aims to improve access to affordable, reliable medications amid ongoing healthcare financial pressures, supporting providers serving millions of patients nationwide.